Loading
journalsJournal
Blood cancer journal
Blood Cancer Journal is a fully open access Nature Portfolio journal on leukaemia, lymphoma, myeloma and related disorders, read by clinical and laboratory haematologists.
Also called: Blood Cancer JournalBlood Cancer J
Overview
Blood Cancer Journal has been published since 2011 by Nature Publishing Group, now part of Springer Nature, from New York. Its homepage describes a peer-reviewed, fully open access journal dedicated to articles of the highest quality on haematological malignancies and related disorders, considering original research, reviews, guidelines and letters, and it runs a Current Treatment Algorithms article type that gives concise treatment pathways for blood cancers. It is listed in DOAJ with CC BY and CC BY-NC-ND licences, an article processing charge and anonymous peer review. Indexed in MEDLINE.
Publisher
Springer Nature (Nature Portfolio)
Scope
haematological oncology
Website
Access model
open access
Founded
2011
ISSN
2044-5385
guideline2021changed practice141 citations
IMWG consensus definition of primary plasma cell leukaemia at 5 percent circulating plasma cells
More patients now receive the diagnosis and the intensive, transplant-based approach that goes with it; trial eligibility uses the new definition.
observational2020changed practice228 citations
IMWG 20/2/20 risk stratification model for smouldering multiple myeloma
The 20/2/20 model defines high-risk smouldering myeloma in current guidelines and trial eligibility, including in AQUILA-informed practice.
review2017208 citations
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
One of the most cited reviews Europe PMC returns for CD30 in Hodgkin lymphoma, so it is a natural first reading for anyone weighing the idea it is linked from. The record was linked automatically by title and abstract; read the abstract above and the paper itself before relying on any figure.
Joaquín Martínez-López
Head of the Haematology Department
Multiple myelomaHaematological malignanciesMinimal residual disease
Haematologist who heads the Haematology Department at Hospital 12 de Octubre and the joint H12O-CNIO haematological malignancies unit, known for myeloma and MRD research.
Pierre Vera
Directeur Général (Director General), Centre Henri Becquerel
Nuclear medicineCancer imagingCancer centre management
Nuclear medicine physician who directs Centre Henri Becquerel, the comprehensive cancer centre for the Rouen area in Normandy.
Sigurdur Y. Kristinsson
Professor of Hematology, University of Iceland; Landspitali University Hospital
Myeloma precursor conditionsPopulation screeningEpidemiology
Leads iStopMM, which screened most of Iceland's adults for myeloma precursors to test whether early detection helps.
guidelineBlood cancer journal 2021changed practice141 citations
IMWG consensus definition of primary plasma cell leukaemia at 5 percent circulating plasma cells
More patients now receive the diagnosis and the intensive, transplant-based approach that goes with it; trial eligibility uses the new definition.
observationalBlood cancer journal 2020changed practice228 citations
IMWG 20/2/20 risk stratification model for smouldering multiple myeloma
The 20/2/20 model defines high-risk smouldering myeloma in current guidelines and trial eligibility, including in AQUILA-informed practice.
reviewBlood cancer journal 2017208 citations
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
One of the most cited reviews Europe PMC returns for CD30 in Hodgkin lymphoma, so it is a natural first reading for anyone weighing the idea it is linked from. The record was linked automatically by title and abstract; read the abstract above and the paper itself before relying on any figure.
Similar pages
- JournalBlood cancer discovery
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Multiple myeloma.
- JournalCurrent hematologic malignancy reports
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Multiple myeloma.
- TrialiStopMM
Shares Sigurdur Y. Kristinsson, Multiple myeloma.
- InstitutionCentre Henri Becquerel
Shares Pierre Vera, Diffuse large B-cell lymphoma.
- JournalClinical lymphoma, myeloma & leukemia
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Multiple myeloma.
- JournalLeukemia & lymphoma
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Multiple myeloma.
- JournalCritical reviews in oncology/hematology
Shares Pierre Vera, PubMed & Europe PMC.
- JournalLeukemia research
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia.